Allou reports double-digit sales growth for H&BAs, fragrances/cosmetics, pharmaceuticals.
This article was originally published in The Rose Sheet
Executive Summary
ALLOU H&BA SALES CLIMB 10% TO $22.8 MIL. IN THE THIRD QUARTER (ended Dec. 31) due to new product introductions from manufacturers and increased same-store sales, the Brentwood, NY-based H&BA, cosmetics, fragrances and prescription drug distributor announced Feb. 14. Health and beauty aid revenues accounted for 33.3% of Allou Health & Beauty Care sales of $69 mil. in the three-month period. For the nine months, H&BA sales were ahead 13% to $64.5 mil.
|
ALLOU H&BA SALES CLIMB 10% TO $22.8 MIL. IN THE THIRD QUARTER (ended Dec. 31) due to new product introductions from manufacturers and increased same-store sales, the Brentwood, NY-based H&BA, cosmetics, fragrances and prescription drug distributor announced Feb. 14. Health and beauty aid revenues accounted for 33.3% of Allou Health & Beauty Care sales of $69 mil. in the three-month period. For the nine months, H&BA sales were ahead 13% to $64.5 mil. Allou is considering expansion of its H&BA business via an acquisition, most likely in the Midwest or West Coast, the company said. Currently, the firm's distribution of H&BAs is limited to the northeast and Miami areas. Allou's most recent expansion -- the March 1993 acquisition of the M. Sobol branded prescription pharmaceuticals business -- contributed to a nearly three-fold increase in third quarter sales for the prescription drug segment to $10.8 mil., compared to $3.9 mil. in the year-earlier period. For the nine months, sales almost doubled to $23.9 mil. The firm's pharmaceuticals business, driven during the quarter by increased marketing efforts and the addition of generic drugs, accounted for 15.7% of the company's consolidated sales. Allou total sales rose 28.8% in the quarter, while net earnings rose 35.8% to $1.4 mil. In the nine months, consolidated sales were $181.8 mil. (up 20.5%), with earnings growing 18.3% to $3.4 mil. Allou's second largest segment during the quarter -- fragrances and cosmetics -- represented 32% of total sales. Revenues for the business advanced 21% to $22 mil. for the three-month period, based in part on an expanded customer base for prestige fragrances, the firm said. In the nine-month period, fragrance and cosmetics sales climbed 14% to $58.6 mil. |